For this year's post-ASCO Lung Cancer panel discussion, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Center, and Founder and President of GRACE, Christine Lovly, Associate Professor of Medicine, Division of Hematology-Oncology, and Dr. Alfredo Addeo, Medical Oncologist, department of Oncology at the University Hospital of Geneva (HUG), discuss the most current and emerging treatment information recently presented at ASCO.
Drs. West, Lovly, and Addeo review key information from 2023 ASCO on lung cancer developments, including the results of several trials.
In this video, Drs. West, Lovly, and Addeo examine treatment options for patients with EGFR+ disease, who also have acquired resistance to EGFR inhibitor therapy.
For more, please visit [ Ссылка ].
To join the conversation, visit [ Ссылка ].
Sound Used: Once Again (BenSound.com)
License #: 2LN6RROJA08RATWY
